J BONE ONCOL 2021 10.1016/j.jbo.2021.100368

Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases

Kim¹, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS

CANCERS 2021 10.3390/cancers13081913

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma

Park¹, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM

CANCERS 2021 10.3390/cancers13071549

Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients

Yoon¹, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S

ORAL ONCOL 2021 10.1016/j.oraloncology.2021.105180

Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients

Yang¹, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM

KOREAN J INTERN MED 2021 10.3904/kjim.2019.161

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer

Lim¹, SH; Sun, JM; Hong, J; Oh, D; Ahn, YC; Chung, MK; Jeong, HS; Son, YI; Ahn, MJ; Baek, CH; Park, K

CANCER RES TREAT 2021 10.4143/crt.2020.572

Development of a Tongue Immobilization Device Using a 3D Printer for Intensity Modulated Radiation Therapy of Nasopharyngeal Cancer Patients

Ju¹, SG; Ahn, YC; Kim, YB; Park, SG; Choi, YM; Na, CH; Hong, CS; Oh, D; Kwon, DY; Kim, CC; Kim, DH

J THORAC DIS 2020 10.21037/jtd-20-667

Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD a cohort study

Kang¹, N; Shin, SH; Noh, JM; Kang, D; Kim, H; Kwon, OJ; Pyo, H; Ahn, YC; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM; Cho, J; Park, HY

LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Jung¹, HA; Noh, JM; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Pyo, H; Ahn, YC; Park, K

Journal of thoracic disease 2020 10.21037/jtd.2020.03.23

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery

Shin¹, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM

CANCERS 2020 10.3390/cancers12040925

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Yoon¹, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM

J THORAC ONCOL 2020 10.1016/j.jtho.2019.10.022

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC

Tan¹, WL; Chua, KLM; Lin, CC; Lee, VHF; Tho, LM; Chan, AW; Ho, GF; Reungwetwattana, T; Yang, JC; Kim, DW; Soo, RA; Ahn, YC; Onishi, H; Ahn, MJ; Mok, TSK; Tan, DSW; Yang, F

ANN ONCOL 2020 10.1016/j.annonc.2019.10.026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Park¹, K; Vansteenkiste, J; Lee, KH; Pentheroudakis, G; Zhou, C; Prabhash, K; Seto, T; Voon, PJ; Tan, DSW; Yang, JCH; Wang, J; Babu, KG; Nakayama, Y; Alip, A; Chua, KLM; Cheng, JCH; Senan, S; Ahn, YC; Kim, TY; Ahn, HK; Peters, S; Yoshino, T; Douillard, JY

HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067

Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review

Lee¹, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH

RESP RES 2020 10.1186/s12931-019-1254-0

Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer

Shin¹, S; Choi, YS; Jung, JJ; Im, Y; Shin, SH; Kang, D; Cho, JH; Kim, HK; Kim, J; Zo, JI; Shim, YM; Park, K; Ahn, MJ; Ahn, YC; Lee, G; Cho, J; Lee, HY; Park, HY

INT J RADIAT ONCOL 2019 10.1016/j.ijrobp.2019.06.2540

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

Lee¹, AW; Ng, WT; Pan, JJ; Chiang, CL; Poh, SS; Choi, HC; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Sanguineti, G; Soong, YL; Tao, YA; Yom, SS; Wee, JT

Journal of thoracic disease 2019 10.21037/jtd.2019.10.18

Improved clinical outcomes following additional aggressive local consolidative therapy to systemic therapy for oligometastasis from lung cancer: where do we stand between "reality" and "illusion"?

Nam¹, H; Noh, JM; Park, SG; Ahn, YC

Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759

Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy

Kim¹, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY

J RADIAT RES 2019 10.1093/jrr/rrz040

Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score

Kim¹, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D

CANCER SCI 2019 10.1111/cas.14115

Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer

Park¹, SG; Ahn, YC; Oh, D; Noh, JM; Ju, SG; Kwon, D; Jo, K; Chung, K; Chung, E; Lee, W; Park, S

EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04387-4

Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment

Kim¹, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY

CANCER RES TREAT 2019 10.4143/crt.2018.415

Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study

Chung¹, E; Noh, JM; Lee, KC; Kim, JH; Chung, WK; Suh, YG; Lee, JA; Seol, KH; Wu, HG; Kim, YS; Noh, OK; Park, JW; Lee, DS; Lee, J; Kim, YS; Park, WY; Kang, MK; Jo, S; Ahn, YC

RADIAT ONCOL 2019 10.1186/s13014-019-1289-x

Development of a semi-customized tongue displacement device using a 3D printer for head and neck IMRT

Hong¹, CS; Oh, D; Ju, SG; Ahn, YC; Na, CH; Kwon, DY; Kim, CC

CANCER RES TREAT 2019 10.4143/crt.2018.125

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Park¹, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

RADIOTHER ONCOL 2019 10.1016/j.radonc.2019.01.005

Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery

Cho¹, WK; Oh, D; Kim, HK; Ahn, YC; Noh, JM; Shim, YM; Zo, JI; Choi, YS; Sun, JM; Lee, SH; Ahn, MJ; Park, K; Nam, H

CANCER RES TREAT 2019 10.4143/crt.2018.366

Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer

Lee¹, KH; Ahn, YC; Pyo, H; Noh, JM; Park, SG; Kim, TG; Lee, E; Nam, H; Lee, H; Sun, JM; Ahn, JS; Ahn, MJ; Park, K

CANCER RES TREAT 2019 10.4143/crt.2018.240

Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients

Cho¹, WK; Oh, D; Lee, E; Kim, TG; Lee, H; Nam, H; Noh, JM; Ahn, YC

CANCER RES TREAT 2019 10.4143/crt.2018.190

Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma

Lee¹, H; Oh, D; Yang, K; Ko, YH; Ahn, YC; Kim, WS; Kim, SJ

J RADIAT RES 2019 10.1093/jrr/rry102

Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?

Yoo¹, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH

CANCER RES TREAT 2019 10.4143/crt.2017.273

The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)

Ha¹, B; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Kim, YS; Wu, HG; Kim, JH; Ahn, YC; Oh, D; Noh, JM; Lee, JH; Kim, SH; Kim, WT; Oh, YT; Kang, MK; Kim, JH; Kim, JY; Cho, MJ; Kay, CS; Choi, JH

RADIAT ONCOL 2018 10.1186/s13014-018-1196-6

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion

Kim¹, H; Oh, D; Ahn, YC; Park, K; Ahn, MJ; Lee, SH; Sun, JM; Shim, YM; Zo, JI; Choi, YS; Kim, HK; Cho, JH

INT J RADIAT ONCOL 2018 10.1016/j.ijrobp.2018.07.2022

Patterns of Failure Following Postoperative Radiation Therapy Based on "Tumor Bed With Margin" for Stage II to IV Type C Thymic Epithelial Tumor

Lee¹, KH; Noh, JM; Ahn, YC; Oh, D; Kim, J; Shim, YM; Han, JH

CANCER RES TREAT 2018 10.4143/crt.2017.182

Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell

Lee¹, GI; Oh, D; Kim, WS; Kim, SJ; Ko, YH; Woo, KI; Kim, YD; Ahn, YC

RADIOTHER ONCOL 2018 10.1016/j.radonc.2017.10.032

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

Lee¹, AW; Ng, WT; Pan, JJ; Poh, SS; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Soong, YL; Tao, YG; Yom, SS; Wee, JT

HEAD NECK-J SCI SPEC 2018 10.1002/hed.24980

Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis

So¹, YK; Oh, D; Choi, N; Baek, CH; Ahn, YC; Chung, MK

LUNG CANCER 2018 10.1016/j.lungcan.2017.11.020

Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer

Lee¹, J; Kim, HK; Park, BJ; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Pyo, H; Ahn, YC; Ahn, JS; Ahn, MJ; Park, K; Kim, J

J THORAC ONCOL 2017 10.1016/j.jtho.2017.09.1954

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer

Sun¹, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K

JPN J CLIN ONCOL 2017 10.1093/jjco/hyx120

Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy

Park¹, JS; Lim, DH; Ahn, YC; Park, W; Kim, SJ; Kim, WS; Kim, K

RADIAT ONCOL 2017 10.1186/s13014-017-0905-x

Normal lung sparing Tomotherapy technique in stage III lung cancer

Hong¹, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K

CANCER RES TREAT 2017 10.4143/crt.2016.425

Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07)

Kim¹, Y; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Lee, SW; Ahn, YC; Oh, D; Kim, YS; Won, YK; Wu, HG; Hah, JH; Oh, YT

CANCER RES TREAT 2017 10.4143/crt.2016.442

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience

Park¹, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM

BMC CANCER 2017 10.1186/s12885-017-3571-3

Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study

Song¹, S; Wu, HG; Lee, CG; Keum, KC; Kim, MS; Ahn, YC; Oh, D; Park, HJ; Lee, SW; Park, G; Moon, SH; Cho, KH; Kim, YS; Won, Y; Oh, YT; Kim, WT; Jeong, JU

CANCER RES TREAT 2017 10.4143/crt.2016.219

Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea

Song¹, S; Chang, JH; Kim, HJ; Kim, YS; Kim, JH; Ahn, YC; Kim, JS; Song, SY; Moon, SH; Cho, MJ; Youn, SM

Pathol Res Pract. 2017 Feb;213(2):106-112. doi: 10.1016/j.prp.2016.11.012. Epub 2016 Nov 15.

Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature

Kwon AY1¹, Han J2, Chu J1, Choi YS3, Jeong BH4, Ahn MJ5, Ahn YC6.

RADIOTHERAPY AND ONCOLOGY, FEB 2017, 122(2):217-223, DOI: 10.1016/j.radonc.2016.09.015

A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer

Lee JY¹, Sun JM, Oh D, Lim SH, Chi S, Lee SH, Jung SH, Ahn MJ, Ahn YC, Park K

Oncotarget. 2017 Jan 10;8(2):3542-3552. doi: 10.18632/oncotarget.12200.

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery

Cho WK1¹, Oh D1, Ahn YC1, Shim YM2, Zo JI2, Sun JM3, Ahn MJ3, Park K3.

J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26.

Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study

Yu JI1¹, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.

Ann Hematol. 2016 Mar;95(4):581-91. doi: 10.1007/s00277-015-2581-y. Epub 2016 Jan 4.

Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability

Kim SM1¹, Park S1, Oh DR2, Ahn YC2, Ko YH3, Kim SJ1, Kim WS4.

Radiother Oncol. 2016 Feb;118(2):244-50. doi: 10.1016/j.radonc.2015.11.030. Epub 2015 Dec 17.

Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)

Lee JY1¹, Sun JM1, Oh DR2, Lim SH1, Goo J3, Lee SH1, Kim SB4, Park KU5, Kim HK6, Hong DS7, Kim JS8, Kim SG9, Yi SY10, Yun HJ11, Hyun MS12, Kim HJ13, Jung SH3, Park K1, Ahn YC14, Ahn MJ15.

J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14.

Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?

Kim H1¹, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.

Ann Surg Oncol. 2016 Dec;23(13):4368-4375. Epub 2016 Jun 24.

Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy

Cho JK1¹, Lim BW1, Kim EH2, Ko YH3, Oh D4, Noh JM4, Ahn YC4, Baek KH5, Jeong HS6.

BRITISH JOURNAL OF RADIOLOGY, 2016, 89(1067), DOI: 10.1259/bjr.20160109

Value of F-18-FDG heterogeneity for discerning metastatic from benign lymph nodes in nasopharyngeal carcinoma patients with suspected recurrence

Moon SH¹, Cho YS, Son YI, Ahn YC, Ahn MJ, Choi JY, Kim BT, Lee KH

Cancer Res Treat. 2016 Oct;48(4):1187-1195. Epub 2016 Mar 9.

Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules

Cho WK1¹, Noh JM1, Ahn YC1, Oh D1, Pyo H1.

Cancer Res Treat. 2016 Jan;48(1):106-14. doi: 10.4143/crt.2014.131. Epub 2015 Feb 12.

Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Noh JM1¹, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.

Cancer Res Treat. 2016 Jan;48(1):63-70. doi: 10.4143/crt.2014.265. Epub 2015 Mar 6.

Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer

Hong CS1¹, Oh D1, Ju SG1, Ahn YC1, Noh JM1, Chung K1, Kim JS1, Suh TS2.

Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26.

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Lim SH1¹, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.

Otolaryngol Head Neck Surg. 2016 Sep;155(3):423-30. doi: 10.1177/0194599816642418. Epub 2016 Apr 5.

Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer

Chung MK1¹, Kim do H2, Ahn YC3, Choi JY4, Kim EH1, Son YI5.

Oncotarget. 2016 Sep 13;7(37):60639-60646. doi: 10.18632/oncotarget.10259.

Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma

Noh JM1¹, Lee E1, Ahn YC1, Oh D1, Kim YD2, Woo KI2, Ko YH3, Kim S3.

Medicine (Baltimore). 2016 Aug;95(33):e4591. doi: 10.1097/MD.0000000000004591.

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma

Oh D1¹, Noh JM, Nam H, Lee H, Kim TG, Ahn YC.

Cancer Res Treat. 2016 Jul;48(3):917-27. doi: 10.4143/crt.2015.265. Epub 2015 Dec 28.

The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis

Song JH1¹, Wu HG2, Keam BS3, Hah JH4, Ahn YC5, Oh D5, Noh JM5, Park HJ5, Lee CG6, Keum KC6, Cha J6, Cho KH7, Moon SH7, Kim JY8, Chung WK9, Oh YT10, Kim WT11, Cho MJ12, Kay CS13, Kim YS14.

Cancer Res Treat. 2016 Jul;48(3):1102-9. doi: 10.4143/crt.2015.207. Epub 2015 Dec 2.

Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014

Yu JI1¹, Park HC1,2, Ahn YC1,2, Chung Y1, Koom WS3, Song SY4.

Ann Surg Oncol. 2016 Jun;23(6):2054-61. doi: 10.1245/s10434-016-5088-4. Epub 2016 Jan 19.

Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer

Jang JY1¹, Kim EH2, Cho J2, Jung JH3, Oh D4, Ahn YC4, Son YI2, Jeong HS5.

Strahlenther Onkol. 2016 Jun;192(6):377-85. doi: 10.1007/s00066-016-0959-y. Epub 2016 Mar 14.

IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)

Moon SH1¹, Cho KH2, Lee CG3, Keum KC3, Kim YS4, Wu HG5, Kim JH5, Ahn YC6, Oh D6, Lee JH7.

Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29.

Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease

Kim HK1¹, Cho JH1, Choi YS1, Zo JI1, Shim YM1, Park K2, Ahn MJ2, Ahn YC3, Kim K4, Kim J5.

Head Neck. 2016 Apr;38 Suppl 1:E293-9. doi: 10.1002/hed.23988. Epub 2015 Jun 26.

Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy

Chang JH1¹,2, Ahn YC1, Park H1, Oh D1, Noh JM1, Sun JM3, Ahn MJ3, Park K3.

Cancer Res Treat. 2016 Apr;48(2):537-45. doi: 10.4143/crt.2015.081. Epub 2015 Jul 14.

Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer

Lee H1¹, Ahn YC2, Oh D2, Nam H1, Noh JM2, Park SY2,3.

Cancer Res Treat. 2016 Apr;48(2):527-36. doi: 10.4143/crt.2015.249. Epub 2015 Sep 15.

Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma

Kim HS1¹, Lee JY1, Lim SH1, Park K1, Sun JM1, Ko YH2, Baek CH3, Son YI3, Jeong HS3, Ahn YC4, Lee MY5, Hong M6, Ahn MJ1.

J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6.

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04

Ahn JS1¹, Ahn YC1, Kim JH1, Lee CG1, Cho EK1, Lee KC1, Chen M1, Kim DW1, Kim HK1, Min YJ1, Kang JH1, Choi JH1, Kim SW1, Zhu G1, Wu YL1, Kim SR1, Lee KH1, Song HS1, Choi YL1, Sun JM1, Jung SH1, Ahn MJ1, Park K2.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):677-83. doi: 10.1016/j.ijrobp.2015.07.2267. Epub 2015 Jul 22.

Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Oh D1¹, Ahn YC2, Kim SJ3, Kim WS3, Ko YH4.

Cancer Res Treat. 2015 Oct;47(4):645-52. doi: 10.4143/crt.2014.144. Epub 2015 Feb 12.

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer

Noh JM1¹, Ahn YC1, Lee H2, Pyo H1, Kim B1, Oh D1, Park H1, Lee E1, Park K3, Ahn JS3, Ahn MJ3, Sun JM3.

Cancer Res Treat. 2015 Oct;47(4):871-8. doi: 10.4143/crt.2014.141. Epub 2015 Feb 13.

Role of Chemotherapy in Stacie II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy

Kang MK1¹, Oh D2, Cho KH3, Moon SH3, Wu HG4, Heo DS5, Ahn YC2, Park K6, Park HJ2, Park JS2, Keum KC7, Cha J7, Kim JW7, Kim YS8, Kang JH9, Oh YT10, Kim JY11, Kim SH12, Kim JH13, Lee CG7.

Int Forum Allergy Rhinol. 2015 Oct;5(10):960-6. doi: 10.1002/alr.21564. Epub 2015 Jun 3.

Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type

Cho HJ1¹, Jang MS2, Hong SD2, Kim SJ3, Ahn YC4, Oh D4, Ko YH5, Kim HY2, Dhong HJ2, Chung SK2, Kim WS3.

Cancer Res Treat. 2015 Oct;47(4):727-37. doi: 10.4143/crt.2014.018. Epub 2014 Dec 2.

Dosimetric and Clinical Influence of 3D Versus 2D Planning in Postoperative Radiation Therapy for Gastric Cancer

Lee JA1¹, Ahn YC2, Lim do H2, Park HC2, Asranbaeva MS3.

Radiother Oncol. 2015 Oct;117(1):171-7. doi: 10.1016/j.radonc.2015.08.009. Epub 2015 Aug 20.

Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial

Yu JI1¹, Lim do H2, Ahn YC1, Lee J3, Kang WK3, Park SH3, Park JO3, Park YS3, Lim HY3, Kim ST3, Kim S4, Sohn TS4, Choi MG4, Bae JM4, Nam H5.

Cancer Chemother Pharmacol. 2015 Jan;75(1):77-85. doi: 10.1007/s00280-014-2619-1. Epub 2014 Nov 6.

Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery

Lim HJ1¹, Lee HY, Lee KS, Han J, Kwon OJ, Park K, Ahn YC, Kim BT, Shim YM.

AJR Am J Roentgenol.?2015 Sep;205(3):623-8. doi: 10.2214/AJR.14.13847.

Volume-Based Assessment With F-18-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer

Hyun SH1¹,?Ahn HK2,?Ahn MJ3,?Ahn YC4,?Kim J5,?Shim YM5,?Choi JY1.

Cancer Res Treat.?2015 Jul;47(3):436-40. doi: 10.4143/crt.2013.184. Epub 2014 Nov 17.

Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck

Noh JM1¹,?Ha SY2,?Ahn YC1,?Oh D1,?Seol SW1,?Oh YL2,?Han J2.

Eur J Cancer. 2015 Jul;51(10):1303-11. doi: 10.1016/j.ejca.2015.04.003. Epub 2015 Apr 28.

Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients

Cho JK1¹, Lee GJ2, Yi KI3, Cho KS3, Choi N2, Kim JS2, Kim H4, Oh D4, Choi SK5, Jung SH5, Jeong HS2, Ahn YC6.

Clin Exp Otorhinolaryngol. 2015 Jun;8(2):142-8. doi: 10.3342/ceo.2015.8.2.142. Epub 2015 May 13.

Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy

Moon SH1¹, Choi JY1, Lee HJ1, Son YI2, Baek CH2, Ahn YC3, Ahn MJ4, Park K4, Kim BT1.

J Thorac Oncol.?2015 Feb;10(2):331-7. doi: 10.1097/JTO.0000000000000388.

Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non-Small-Cell Lung Cancer

Um SW1¹,?Kim HK,?Jung SH,?Han J,?Lee KJ,?Park HY,?Choi YS,?Shim YM,?Ahn MJ,?Park K,?Ahn YC,?Choi JY,?Lee KS,?Suh GY,?Chung MP,?Kwon OJ,?Kim J,?Kim H

CANCER IMAGING, APR 22 2014, 14, 10.1186/1470-7330-14-2

Prognostic value of volumetric metabolic parameters measured by [F-18]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer

Park¹, SB, Choi, JY, Moon, SH, Yoo, J, Kim, H, Ahn, YC, Ahn, MJ, Park, K, Kim, BT

PLoS One. 2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014.

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy

Chong Y1¹, Kim JH1, Lee HY1, Ahn YC2, Lee KS1, Ahn MJ3, Kim J4, Shim YM4, Han J5, Choi YL5.

Ann Hematol. 2014 Nov;93(11):1895-901. doi: 10.1007/s00277-014-2137-6. Epub 2014 Jun 20.

Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study

Kim SJ1¹, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, Won JH, Lee JH, Yoon DH, Cho J, Nam TK, Lee SW, Ahn YC, Suh C, Kim WS.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):50-8. doi: 10.1007/s00259-013-2530-8. Epub 2013 Aug 16.

Volume-based assessment by F-18-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

Hyun SH1¹, Ahn HK, Kim H, Ahn MJ, Park K, Ahn YC, Kim J, Shim YM, Choi JY.

Clin Lung Cancer. 2014 Sep;15(5):346-55. doi: 10.1016/j.cllc.2014.04.003. Epub 2014 May 15.

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer

Ashworth AB1¹, Senan S2, Palma DA1, Riquet M3, Ahn YC4, Ricardi U5, Congedo MT6, Gomez DR7, Wright GM8, Melloni G9, Milano MT10, Sole CV11, De Pas TM12, Carter DL13, Warner AJ1, Rodrigues GB14.

Ann Surg Oncol. 2014 Jun;21(6):2083-90. doi: 10.1245/s10434-014-3540-x. Epub 2014 Feb 13.

Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy

Lee H1¹, Ahn YC, Pyo H, Kim B, Oh D, Nam H, Lee E, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM.

Head Neck. 2014 Apr;36(4):499-504. doi: 10.1002/hed.23328. Epub 2013 Jun 18.

Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer

Lee H1¹, Ahn YC, Oh D, Nam H, Kim YI, Park SY.

Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22.

Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy

Kim H1¹, Chie EK2, Ahn YC3, Kim K2, Park W3, Yoon WS4, Huh SJ3, Ha SW2.

Med Phys.?2014 Feb;41(2):021712. doi: 10.1118/1.4860155.

Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer

Hong CS1¹,?Ju SG1,?Kim M1,?Kim JI2,?Kim JM1,?Suh TS3,?Han Y1,?Ahn YC1,?Choi DH1,?Nam H2,?Park HC1.

J Cancer Res Clin Oncol. 2013 Dec;139(12):2089-96. doi: 10.1007/s00432-013-1531-0. Epub 2013 Oct 10.

A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea

Chung Y1¹, Koom WS, Ahn YC, Park HC, Kim HJ, Yoon SM, Shin S, Lee YJ.

Ann Oncol. 2013 Aug;24(8):2088-92. doi: 10.1093/annonc/mdt140. Epub 2013 Apr 16.

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer(dagger)

Sun JM1¹, Ahn YC, Choi EK, Ahn MJ, Ahn JS, Lee SH, Lee DH, Pyo H, Song SY, Jung SH, Jo JS, Jo J, Sohn HJ, Suh C, Lee JS, Kim SW, Park K.

J Thorac Oncol. 2013 May;8(5):624-9. doi: 10.1097/JTO.0b013e31828cb6db.

Hypofractionated Three-Dimensional Conformal Radiation Therapy Alone for Centrally Located cT1-3N0 Non-Small-Cell Lung Cancer

Oh D1¹, Ahn YC, Kim B, Pyo H.

Yonsei Med J. 2012 Nov 1;53(6):1120-7. doi: 10.3349/ymj.2012.53.6.1120.

High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer

Bae SH1¹, Ahn YC, Nam H, Park HC, Pyo HR, Shim YM, Kim J, Kim K, Ahn JS, Ahn MJ, Park K.

Cancer Res Treat. 2012 Sep;44(3):166-72. doi: 10.4143/crt.2012.44.3.166. Epub 2012 Sep 30.

Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor

Oh D1¹, Ahn YC, Kim K, Kim J, Shim YM, Han J.

Clin Exp Otorhinolaryngol. 2012 Jun;5(2):94-100. doi: 10.3342/ceo.2012.5.2.94. Epub 2012 Jun 12.

Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules

Kim TG1¹, Ahn YC, Nam HR, Chung MK, Jeong HS, Son YI, Baek CH.

Acta Oncol. 2012 May;51(5):596-602. doi: 10.3109/0284186X.2012.681698. Epub 2012 May 1.

Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung

Oh D1¹, Ahn YC, Seo JM, Shin EH, Park HC, Lim do H, Pyo H.

Med Phys. 2012 May;39(5):2396-404. doi: 10.1118/1.3700734.

Development of a video-guided real-time patient motion monitoring system

Ju SG1¹, Huh W, Hong CS, Kim JS, Shin JS, Shin E, Han Y, Ahn YC, Park HC, Choi DH.

Indian J Exp Biol. 2012 Mar;50(3):195-200.

Protective effect of triphala on radiation induced acute intestinal mucosal damage in Sprague Dawley rats

Yoon WS1¹, Kim CY, Yang DS, Park YJ, Park W, Ahn YC, Kim SH, Kwon GY.

Introduction of intensity modulated radiation therapy

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):507-12. doi: 10.1016/j.ijrobp.2009.07.1706. Epub 2010 Jan 7.

INVOLVED-LESION RADIATION THERAPY AFTER CHEMOTHERAPY IN LIMITED-STAGE HEAD-AND-NECK DIFFUSE LARGE B CELL LYMPHOMA

Yu JI1¹, Nam H, Ahn YC, Kim WS, Park K, Kim SJ.

Med Phys.?2010 Jun;37(6):2925-33.

Comparison of film dosimetry techniques used for quality assurance of intensity modulated radiation therapy

Ju SG1¹,?Han Y,?Kum O,?Cheong KH,?Shin EH,?Shin JS,?Kim JS,?Ahn YC.

Clin Exp Otorhinolaryngol. 2010 Jun;3(2):96-101. doi: 10.3342/ceo.2010.3.2.96. Epub 2010 Jun 30.

Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy

Noh JM1¹, Ahn YC, Nam H, Park W, Baek CH, Son YI, Jeong HS.

J Thorac Oncol. 2010 Apr;5(4):526-32. doi: 10.1097/JTO.0b013e3181cbf622.

Results and Prognostic Factors of Hypofractionated Stereotactic Radiation Therapy for Primary or Metastatic Lung Cancer

Kim H1¹, Ahn YC, Park HC, Lim do H, Nam H.

Cancer. 2009 Aug 15;115(16):3699-708. doi: 10.1002/cncr.24414.

Therapeutic Effect of Recombinant Human Epidermal Growth Factor (RhEGF) on Mucositis in Patients Undergoing Radiotherapy, With or Without Chemotherapy, for Head And Neck Cancer A Double-blind Placebo-controlled Prospective Phase 2 Multi-institutional Clinical Trial

Wu HG1¹, Song SY, Kim YS, Oh YT, Lee CG, Keum KC, Ahn YC, Lee SW.

Jpn J Clin Oncol. 2009 Mar;39(3):151-7. doi: 10.1093/jjco/hyn158. Epub 2009 Feb 3.

Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors

Oh D1¹, Ahn YC, Park HC, Lim do H, Han Y.

Radiother Oncol. 2009 Feb;90(2):236-41. doi: 10.1016/j.radonc.2008.09.011. Epub 2008 Oct 22.

Prognostic significance of anatomic subsites: Results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma

Nam H1¹, Ahn YC, Kim YD, Ko Y, Kim WS.

Med Phys. 2008 Jun;35(6):2519-27.

Dosimetry in an IMRT phantom designed for a remote monitoring program

Han Y1¹, Shin EH, Lim C, Kang SK, Park SH, Lah JE, Suh TS, Yoon M, Lee SB, Cho SH, Ibbott GS, Ju SG, Ahn YC.

Jpn J Clin Oncol. 2008 Feb;38(2):92-8. doi: 10.1093/jjco/hym159. Epub 2008 Feb 11.

High-dose thoracic radiation therapy at 3.0 Gy/fraction in inoperable stage I/II non-small cell lung cancer

Kim B1¹, Ahn YC, Lim do H, Nam HR.

Cancer Lett. 2007 Dec 8;258(1):90-7.

Nongastric marginal zone B-cell lymphoma: A prognostic model from a retrospective multicenter study

Oh SY1¹, Kwon HC, Kim WS, Park YH, Kim K, Kim HJ, Kwon JM, Lee J, Ko YH, Ahn YC, Oh SJ, Lee SI, Bang SM, Kim JH, Park J, Ryoo BY, Lee SS, Kim HY, Park K, Kim HJ.

Yonsei Med J. 2007 Oct 31;48(5):827-32.

Anal canal carcinoma: Experience from a single Korean institution

Lee WS1¹, Chun HK, Lee WY, Yun SH, Yun H, Cho YB, Kang WK, Park YS, Huh SJ, Ahn YC, Park W.

Lung Cancer. 2007 Mar;55(3):329-36. Epub 2006 Dec 8.

Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer

Kim KJ1¹, Ahn YC, Lim do H, Han J, Park K, Park JO, Kim K, Kim J, Shim YM.

"Yonsei Med J. 2006 Aug 31;47(4):571-4."

Lung metastasis from an immature teratoma of the nasal cavity masquerading as small cell carcinoma of the lung

Kang MK1¹, Ahn YC, Park JO, Han J, Lee KS.

J Korean Med Sci. 2006 Apr;21(2):229-35.

Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer

Kang MK1¹, Ahn YC, Lim DH, Park K, Park JO, Shim YM, Kim J, Kim K.

Haematologica. 2006 Mar;91(3):427-8. Epub 2006 Feb 17.

The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphoma

Lee SH¹, Ahn YC, Kim WS, Ko YH, Kim K, Park K.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1559-64.

Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors

Hashimoto T1¹, Shirato H, Kato M, Yamazaki K, Kurauchi N, Morikawa T, Shimizu S, Ahn YC, Akine Y, Miyasaka K.

Yonsei Med J. 2004 Aug 31;45(4):584-90.

Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer

Ahn YC1¹, Shimizu S, Shirato H, Hashimoto T, Osaka Y, Zhang XQ, Abe T, Hosokawa M, Miyasaka K.

Yonsei Med J. 2004 Feb 29;45(1):100-6.

High dose 3-dimensional re-irradiation for locally recurrent nasopharyngeal cancer

Shin SS1¹, Ahn YC, Lim DH, Park W, Huh SJ.

Med Phys.?2002 Mar;29(3):351-5.

Film dosimetry for intensity modulated radiation therapy: Dosimetric evaluation

Ju SG1¹,?Ahn YC,?Huh SJ,?Yeo IJ.

Cancer.?2009 Aug 15;115(16):3699-708. doi: 10.1002/cncr.24414.

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer

Wu HG1¹,?Song SY,?Kim YS,?Oh YT,?Lee CG,?Keum KC,?Ahn YC,?Lee SW.

Acta Oncol. 2001;40(5):588-92.

Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer

Ahn YC1¹, Park K, Kim DY, Kim KM, Kim J, Shim YM, Lee KS, Han J, Kim HJ, Kwon J, Lim DH, Noh YJ, Lee JE, Huh SJ.

Int J Radiat Oncol Biol Phys.?2000 Sep 1;48(2):541-4.

Physical properties of new collimator cone system for stereotactic radiation therapy developed in Samsung Medical Center

Kim DY1¹,?Ahn YC,?Oh DG,?Choi DR,?Ju SG,?Yeo IH,?Huh SJ.

Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):501-5.

Fractionated stereotactic radiation therapy for extracranial head and neck tumors

Ahn YC1¹, Lee KC, Kim DY, Huh SJ, Yeo IH, Lim DH, Kim MK, Shin KH, Park S, Chang SH.

Head Neck. 1999 Jul;21(4):338-45.

Fractionated stereotactic radiation therapy for locally recurrent nasopharynx cancer: Report of three cases

Ahn YC1¹, Kim DY, Huh SJ, Baek CH, Park K.

Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):435-8.

Design and development of new collimator cones for fractionated stereotactic radiation therapy in Samsung Medical Center

Ahn YC1¹, Ju SG, Kim DY, Choi DR, Huh SJ, Park YH, Lim DH, Kim MK.